MedPath

Hyoscyamine

Hyoscyamine Sulfate Extended-Release Tablets, 0.375 mg Rx only (Packaged by Pharma Packaging Solutions, LLC dba Tjoapack LLC)

Approved
Approval ID

01f97804-a6cb-ce6d-e063-6394a90ae220

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 2, 2023

Manufacturers
FDA

Pharma Packaging Solutions, LLC dba Tjopack LLC

DUNS: 928861723

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

hyoscyamine sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code75929-057
Product Classification
G
Generic Name
hyoscyamine sulfate
Product Specifications
Route of AdministrationORAL
Effective DateAugust 2, 2023
FDA Product Classification

INGREDIENTS (1)

HYOSCYAMINE SULFATEActive
Quantity: 0.375 mg in 1 1
Code: F2R8V82B84
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Hyoscyamine - FDA Drug Approval Details